OPTIMAL RANGE FOR LOW-DENSITY LIPOPROTEIN (LDL) FOR DIABETIC PATIENTS ON STATIN THERAPY FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS
Therapeutic Area: CVD Prevention - Primary and Secondary Background: Cholesterol-lowering medications such as HMG-CoA reductase inhibitors or statins are a guideline recommendation for the prevention of cardiovascular events in patients with diabetes over the age of 40. High-intensity statins can re...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | |
| Опубликовано: |
Elsevier,
2024-09-01T00:00:00Z.
|
| Предметы: | |
| Online-ссылка: | Connect to this object online. |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
| Шифр: |
A1234.567 |
|---|---|
| Копировать 1 | Доступно |